{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:12Z","timestamp":1791357492721,"version":"4.3.1"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.10372","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:06:01Z","timestamp":1594829161000},"page":"e2010372","source":"Crossref","is-referenced-by-count":63,"title":["Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease"],"prefix":"10.1001","volume":"3","author":[{"given":"Giacomo","family":"Koch","sequence":"first","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"},{"name":"Section of Human Physiology, University of Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Motta","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bonn\u00ec","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Pellicciari","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Picazio","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Paolo","family":"Casula","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maiella","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Lorenzo","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Ponzo","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Unit of Statistics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Scaricamazza","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Caltagirone","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy"},{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"zoi200415r1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer\u2019s disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"zoi200415r2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1471-4159.1996.66031113.x","article-title":"Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein\u2013infused rats.","volume":"66","author":"Itoh","year":"1996","journal-title":"J Neurochem"},{"issue":"6","key":"zoi200415r3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/(ISSN)1531-8257","article-title":"Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson\u2019s, Alzheimer\u2019s with parkinsonism, and Alzheimer\u2019s disease.","volume":"12","author":"Joyce","year":"1997","journal-title":"Mov Disord"},{"key":"zoi200415r4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer\u2019s disease: a systematic review and network meta-analysis.","volume":"11","author":"Pan","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"zoi200415r5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainres.2006.10.049","article-title":"Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer\u2019s disease brain.","volume":"1131","author":"Kumar","year":"2007","journal-title":"Brain Res"},{"issue":"1","key":"zoi200415r6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1460-9568.2003.02716.x","article-title":"Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer\u2019s disease.","volume":"18","author":"Kemppainen","year":"2003","journal-title":"Eur J Neurosci"},{"issue":"6112","key":"zoi200415r7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/bmj.1.6112.550","article-title":"Trial of levodopa in senile dementia.","volume":"1","author":"Lewis","year":"1978","journal-title":"BMJ"},{"issue":"1","key":"zoi200415r8","article-title":"Selegiline for Alzheimer\u2019s disease.","author":"Birks","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"zoi200415r9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.22319","article-title":"Apomorphine treatment in Alzheimer mice promoting amyloid-\u00df degradation.","volume":"69","author":"Himeno","year":"2011","journal-title":"Ann Neurol"},{"key":"zoi200415r10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2016.02.021","article-title":"Dopaminergic neurotransmission dysfunction induced by amyloid-\u00df transforms cortical long-term potentiation into long-term depression and produces memory impairment.","volume":"41","author":"Moreno-Castilla","year":"2016","journal-title":"Neurobiol Aging"},{"key":"zoi200415r11","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease.","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"zoi200415r12","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1038\/npp.2009.60","article-title":"Dopamine modulates cholinergic cortical excitability in Alzheimer\u2019s disease patients.","volume":"34","author":"Martorana","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"zoi200415r13","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/npp.2014.119","article-title":"Dopaminergic modulation of cortical plasticity in Alzheimer\u2019s disease patients.","volume":"39","author":"Koch","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"zoi200415r14","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"zoi200415r15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria.","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"zoi200415r16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2012.07.015","article-title":"Dopamine D2-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer\u2019s disease patients.","volume":"64","author":"Martorana","year":"2013","journal-title":"Neuropharmacology"},{"key":"zoi200415r17","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer\u2019s Disease Assessment Scale that broaden its scope. The Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"zoi200415r18","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"11","key":"zoi200415r19","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside.","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"zoi200415r20","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"2","key":"zoi200415r21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamaneurol.2018.3639","article-title":"Effect of cerebellar stimulation on gait and balance recovery in patients with hemiparetic stroke: a randomized clinical trial.","volume":"76","author":"Koch","year":"2019","journal-title":"JAMA Neurol"},{"issue":"12","key":"zoi200415r22","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamapsychiatry.2017.3292","article-title":"Extent of dorsolateral prefrontal cortex plasticity and its association with working memory in patients with Alzheimer disease.","volume":"74","author":"Kumar","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi200415r23","first-page":"294","article-title":"A general overview of adaptive randomization design for clinical trials.","volume":"7","author":"Lin","year":"2016","journal-title":"J Biom Biostat"},{"issue":"6","key":"zoi200415r24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson\u2019s disease: a double-blind, double-dummy, randomised controlled trial.","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"issue":"16","key":"zoi200415r25","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1212\/01.wnl.0000259516.61938.bb","article-title":"Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.","volume":"68","author":"LeWitt","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"zoi200415r26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jagp.2016.02.051","article-title":"Extrapyramidal signs and cognitive subdomains in Alzheimer disease.","volume":"24","author":"Park","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"zoi200415r27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","article-title":"Dopamine and cognitive control in prefrontal cortex.","volume":"23","author":"Ott","year":"2019","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"zoi200415r28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-142508","article-title":"Cognitive impairment precedes and predicts functional impairment in mild Alzheimer\u2019s disease.","volume":"47","author":"Liu-Seifert","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"Pt 1","key":"zoi200415r29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/brain\/awr311","article-title":"Executive deficits are related to the inferior frontal junction in early dementia.","volume":"135","author":"Schroeter","year":"2012","journal-title":"Brain"},{"issue":"3","key":"zoi200415r30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jalz.2010.04.005","article-title":"Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer\u2019s disease.","volume":"7","author":"Marshall","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"zoi200415r31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00415-005-0551-3","article-title":"Cerebral metabolic correlates of four dementia scales in Alzheimer\u2019s disease.","volume":"252","author":"Salmon","year":"2005","journal-title":"J Neurol"},{"issue":"20","key":"zoi200415r32","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia.","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"zoi200415r33","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. translating basic science into clinical care.","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"zoi200415r34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tins.2018.10.002","article-title":"Novelty and dopaminergic modulation of memory persistence: a tale of two systems.","volume":"42","author":"Duszkiewicz","year":"2019","journal-title":"Trends Neurosci"},{"issue":"1","key":"zoi200415r35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-171018","article-title":"Volume and connectivity of the ventral tegmental area are linked to neurocognitive signatures of Alzheimer\u2019s disease in humans.","volume":"63","author":"De Marco","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"zoi200415r36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: cellular heterogeneity, connectivity and behaviour.","volume":"18","author":"Morales","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"7620","key":"zoi200415r37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature19325","article-title":"Locus coeruleus and dopaminergic consolidation of everyday memory.","volume":"537","author":"Takeuchi","year":"2016","journal-title":"Nature"},{"issue":"7","key":"zoi200415r38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","article-title":"Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.","volume":"85","author":"Alcolea","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"zoi200415r39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease.","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi200415r40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease.","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"zoi200415r41","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease.","volume":"378","author":"Egan","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi200415r42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease.","volume":"366","author":"Howard","year":"2012","journal-title":"N Engl J Med"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2768248\/koch_2020_oi_200415_1597249387.43643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T17:18:25Z","timestamp":1597771105000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2768248"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.10372","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]}}}